ILMN · Illumina, Inc.

$215.59 -12.10 (-5.31%) At close · Aug 28

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$34.38B

151.00M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$4.34B -0.7%

FY2025

Net Income

$850M +169.5%

FY2025

Gross Margin

66.08% +0.6pp

FY2025

Operating Margin

18.58% +37.6pp

FY2025

Diluted EPS

$5.45 +170.9%

FY2025

Operating Cash Flow

$1.08B +28.9%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	-1.8%	+6.0%	+6.9%	$4.6B – $4.64B	$4.49B	$4.34B	$4.37B	$4.5B	$4.58B	$4.53B	$3.24B	$3.54B	$3.33B	$2.75B	$2.4B	$2.22B	$1.86B	$1.42B	$1.15B	$1.06B	$902.74M	$666.32M	$573.23M
Cost of Revenue	-3.0%	+7.3%	+8.2%	—	$1.51B	$1.47B	$1.51B	$1.76B	$1.61B	$1.37B	$1.04B	$1.08B	$1.03B	$926M	$732M	$671M	$563.65M	$509.29M	$374.99M	$346.44M	$301.2M	$212.45M	$220.13M
Gross Profit	-1.2%	+5.4%	+6.4%	—	$2.98B	$2.87B	$2.86B	$2.74B	$2.97B	$3.15B	$2.2B	$2.47B	$2.3B	$1.83B	$1.67B	$1.55B	$1.3B	$911.89M	$773.53M	$709.1M	$601.54M	$453.88M	$353.09M
Gross Margin	—	—	—	—	—	66.08%	65.44%	60.92%	64.83%	69.69%	68.01%	69.63%	69.01%	66.35%	69.47%	69.77%	69.72%	64.16%	67.35%	67.18%	66.63%	68.12%	61.6%
Research & Development	-9.9%	+7.2%	+9.2%	—	$960M	$967M	$1.17B	$1.35B	$1.32B	$1.19B	$682M	$647M	$623M	$546M	$504M	$401M	$388.06M	$276.74M	$231.03M	$196.91M	$177.95M	$140.62M	$99.96M
Selling, General & Administrative	-5.7%	+2.9%	+7.7%	—	$1.13B	$1.09B	$1.09B	$1.61B	$1.3B	$2.09B	$941M	$835M	$794M	$674M	$584M	$516M	$466.28M	$381.04M	$285.99M	$261.84M	$220.45M	$176.34M	$148.01M
Amortization of Intangibles	-27.9%	+16.7%	+2.2%	—	$70M	$67M	$130M	$197M	$179M	$75M	$31M	$37M	$39M	$46M	$51M	$54M	$50.67M	$47.12M	$17.07M	$13.62M	$7.8M	$6.68M	$10.44M
Depreciation & Amortization	-11.8%	+7.6%	+7.8%	—	—	$270M	$354M	$432M	$394M	$251M	$187M	$188M	$179M	$156M	$141M	$127M	$112.57M	—	—	—	—	—	—
Restructuring Charges	—	—	—	—	—	$47M	$16M	$52M	—	—	—	—	—	—	—	—	—	—	$3.52M	$8.14M	$0	$0	—
Total Operating Expenses	-33.9%	+4.9%	+8.2%	—	$2.1B	$2.06B	$3.69B	$3.81B	$7.15B	$3.28B	$1.62B	$1.48B	$1.42B	$1.22B	$1.08B	$936M	$783M	$777.78M	$572.78M	$509.64M	$389.89M	$328.28M	$272.64M
Operating Income	—	+6.8%	+2.8%	—	$883M	$807M	-$833M	-$1.07B	-$4.18B	-$123M	$580M	$985M	$883M	$606M	$587M	$613M	$514.71M	$134.11M	$200.75M	$199.46M	$211.65M	$125.6M	$80.46M
Operating Margin	—	—	—	—	—	18.58%	-19.05%	-23.73%	-91.16%	-2.72%	17.91%	27.8%	26.49%	22.02%	24.48%	27.61%	27.65%	9.44%	17.48%	18.9%	23.45%	18.85%	14.04%
EBITDA	—	+7.0%	+3.8%	—	—	$1.08B	-$479M	-$637M	-$3.79B	$128M	$767M	$1.17B	$1.06B	$762M	$728M	$740M	$627.29M	—	—	—	—	—	—
Interest Expense	+57.2%	+15.6%	+8.9%	—	$99M	$101M	$100M	$77M	$26M	$61M	$49M	$52M	$57M	$37M	$33M	$43M	$41.73M	$39.69M	$37.78M	$34.79M	$24.6M	$23.72M	$22.21M
Interest Income	+53.8%	-0.5%	+23.1%	—	$38M	$40M	$46M	$58M	$11M	$0	$41M	$75M	$44M	$19M	$10M	$5M	$3.9M	$4.89M	$16.21M	$7.05M	$8.38M	$11.03M	$12.52M
Other Non-Operating Income	—	+0.2%	—	—	$132M	$279M	-$346M	-$48M	-$157M	$1.01B	$276M	$133M	$11M	$437M	-$26M	-$30M	-$65.95M	$25.21M	$21.86M	-$66.42M	-$26.28M	-$11.47M	-$7.77M
Investment Income (Loss)	—	—	—	—	—	—	—	$0	$0	$899M	$0	$0	—	—	—	—	—	—	—	—	—	—	—
Pretax Income	—	+4.9%	+6.4%	—	$1.02B	$1.09B	-$1.18B	-$1.12B	-$4.34B	$884M	$856M	$1.12B	$894M	$1.04B	$561M	$583M	$448.76M	$159.31M	$222.61M	$133.05M	$185.38M	$114.13M	$72.69M
Income Tax	+51.4%	+3.4%	+6.6%	—	$190M	$236M	$44M	$44M	$68M	$122M	$200M	$128M	$112M	$365M	$133M	$125M	$95.41M	$34.01M	$71.35M	$46.42M	$60.49M	$41.84M	$33.27M
Net Income	—	+5.3%	+6.3%	—	$825M	$850M	-$1.22B	-$1.16B	-$4.4B	$762M	$656M	$1B	$826M	$726M	$463M	$462M	$353.35M	$125.31M	$151.25M	$86.63M	$124.89M	$72.28M	$39.42M
Net Margin	—	—	—	—	—	19.57%	-27.97%	-25.78%	-96.07%	16.84%	20.25%	28.28%	24.78%	26.38%	19.31%	20.81%	18.98%	8.82%	13.17%	8.21%	13.83%	10.85%	6.88%
Net Income Attributable to Noncontrolling Interests	—	—	—	—	—	—	—	—	—	$0	$0	-$12M	-$44M	-$48M	-$35M	-$4M	—	—	—	—	—	—	—
Comprehensive Income	—	+4.6%	+5.9%	—	$854M	$818M	-$1.2B	-$1.17B	-$4.42B	$777M	$653M	$1.01B	$826M	$726M	$462M	$463M	$351.04M	$124.42M	$151.26M	$86.98M	$123.83M	$72.69M	$40.48M
EPS (Basic) USD/shares	—	+4.7%	+5.8%	—	$5.40	$5.47	-$7.69	-$7.34	-$28.00	$4.93	$4.36	$6.62	$5.48	$4.82	$3.01	$3.10	$2.54	$0.97	$1.20	$0.68	$0.98	$0.57	$0.33
EPS (Diluted) USD/shares	—	+4.7%	+6.1%	$5.30 – $5.40*	$5.36	$5.45^G	-$7.69^G	-$7.34^G	-$28.00	$4.90	$4.33	$6.56	$5.41	$4.79	$2.99	$3.02	$2.31	$0.88	$1.10	$0.60	$0.85	$0.52	$0.29
Shares Outstanding (Basic Avg) shares	-0.4%	+0.5%	+0.4%	—	—	155M	159M	158M	157M	154.2M	151.12M	151.12M	151.12M	150.09M	151.12M	149.06M	139.35M	128.58M	126.44M	126.85M	127.04M	126.6M	120.13M
Shares Outstanding (Diluted Avg) shares	-0.2%	+0.5%	+0.2%	—	—	156M	159M	158M	157M	155.23M	152.14M	153.17M	153.17M	152.14M	152.14M	153.17M	153.15M	143.85M	137.44M	142.83M	147.45M	140.93M	137.35M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $4.12B in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

Peer median 6.92×

EV/EBIT

—

Peer median 33.42×

P/E (TTM)

42.48×

Peer median 33.47×

Peer medians compare against the 23 similar-size Diagnostics & Research companies (of 48 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2026	FY2025	FY2024	FY2023	FY2022	FY2020	FY2020	FY2019
Core Illumina	$4,343,000,000	$4,332,000,000	$4,438,000,000	$4,553,000,000	$4,519,000,000	$3,239,000,000	$3,543,000,000	$3,334,000,000
Sequencing	$3,985,000,000	—	$4,112,000,000	$4,171,000,000	$4,109,000,000	$2,879,000,000	$3,068,000,000	—
Microarray	$358,000,000	—	$392,000,000	$413,000,000	$417,000,000	$360,000,000	$475,000,000	—
GRAIL Inc.	$0	$55,000,000	$93,000,000	$55,000,000	$12,000,000	$0	$0	—
Consolidated Variable Interest Entities	—	—	—	—	$0	$0	$1,000,000	$10,000,000

By Geography (USD)

Component	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Americas	$2,406,000,000	$2,441,000,000	$2,521,000,000	$2,479,000,000	$2,358,000,000	$1,744,000,000	$1,970,000,000	$1,864,000,000
United States	$2,243,000,000	$2,288,000,000	$2,359,000,000	$2,290,000,000	$2,195,000,000	$1,655,000,000	$1,859,000,000	$1,779,000,000
Europe	$1,264,000,000	$1,185,000,000	$1,140,000,000	$1,089,000,000	$1,149,000,000	—	—	—
Asia Pacific Middle East and Africa	$430,000,000	$438,000,000	$459,000,000	$544,000,000	$517,000,000	—	—	—
China	$243,000,000	$308,000,000	$384,000,000	$472,000,000	$502,000,000	$342,000,000	$372,000,000	$365,000,000
Asia Pacific	—	—	—	$418,000,000	$377,000,000	$267,000,000	$268,000,000	$253,000,000
EMEA	—	—	—	$1,215,000,000	$1,289,000,000	$886,000,000	$933,000,000	$851,000,000

By Product & Service (USD)

Component	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Consumables	$3,227,000,000	$3,155,000,000	$3,083,000,000	$3,225,000,000	$3,217,000,000	$2,304,000,000	$2,392,000,000	$2,177,000,000
Service	$634,000,000	$716,000,000	$717,000,000	—	—	—	—	—
Instruments	$482,000,000	$501,000,000	$704,000,000	$728,000,000	$751,000,000	$431,000,000	$537,000,000	$572,000,000
Service Other	—	—	—	$631,000,000	$558,000,000	$504,000,000	$614,000,000	$584,000,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	FY2024	FY2023	FY2022	FY2020	FY2020	FY2019	FY2018
Core Illumina	$552,000,000	$481,000,000	$808,000,000	$580,000,000	$1,008,000,000	$970,000,000	$696,000,000
GRAIL Inc.	-$1,621,000,000	-$4,657,000,000	-$931,000,000	$0	$0	—	—
Consolidated Variable Interest Entities	—	—	—	—	-$24,000,000	-$90,000,000	-$92,000,000

Operating Margin by Segment (%)

Component	FY2024	FY2023	FY2022	FY2020	FY2020	FY2019
Core Illumina	12.4%	10.6%	17.9%	17.9%	28.5%	29.1%
GRAIL Inc.	-1743%	-8467.3%	-7758.3%	—	—	—
Consolidated Variable Interest Entities	—	—	—	—	-2400%	-900%

Key facts CIK 1110803 CUSIP 452327109 13F (30d) 661 filings 638 filers Visit website Investor relations